| Target Price | $22.44 |
| Price | $17.74 |
| Potential |
26.49%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Zymeworks Inc. 2026 .
The average Zymeworks Inc. target price is $22.44.
This is
26.49%
register free of charge
$31.50
77.56%
register free of charge
$13.13
25.99%
register free of charge
|
|
| A rating was issued by 16 analysts: 13 Analysts recommend Zymeworks Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Zymeworks Inc. stock has an average upside potential 2026 of
26.49%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 76.30 | 158.53 |
| 0.38% | 107.77% | |
| EBITDA Margin | -145.66% | -22.86% |
| 13.43% | 84.31% | |
| Net Margin | -160.81% | -41.73% |
| 3.00% | 74.05% |
10 Analysts have issued a sales forecast Zymeworks Inc. 2025 . The average Zymeworks Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Zymeworks Inc. EBITDA forecast 2025. The average Zymeworks Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
11 Zymeworks Inc. Analysts have issued a net profit forecast 2025. The average Zymeworks Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.62 | -0.88 |
| 5.81% | 45.68% | |
| P/E | negative | |
| EV/Sales | 6.91 |
11 Analysts have issued a Zymeworks Inc. forecast for earnings per share. The average Zymeworks Inc. EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Oct 16 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Oct 14 2025 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Oct 10 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Aug 11 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 03 2025 |
| TD Securities |
Locked
➜
Locked
|
Locked | May 20 2025 |
| LifeSci Capital |
Locked
➜
Locked
|
Locked | Mar 11 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Oct 16 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Oct 14 2025 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Oct 10 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Aug 11 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 03 2025 |
|
Locked
TD Securities:
Locked
➜
Locked
|
May 20 2025 |
|
Locked
LifeSci Capital:
Locked
➜
Locked
|
Mar 11 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


